|
Nov 27
|
Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference
|
|
Sep 6
|
Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
|
|
Aug 28
|
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
|
|
May 10
|
Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
|
|
May 10
|
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 9
|
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
|
|
May 8
|
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
|
|
May 2
|
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
|
|
Apr 30
|
Trials to watch: Four ALS drugs to keep an eye on
|
|
Apr 12
|
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
|
|
Apr 10
|
Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
|
|
Apr 10
|
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
|
|
Apr 10
|
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
|
|
Apr 8
|
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
|
|
Apr 6
|
Analysts Just Slashed Their Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) EPS Numbers
|
|
Apr 4
|
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
|
|
Apr 4
|
ALS drug will be pulled from US market after study showed patients didn't benefit
|
|
Apr 4
|
UPDATE 1-Amylyx Pharma to remove ALS drug from US, Canada markets
|
|
Apr 4
|
Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market
|